Skip to content
Screener

Goodwill at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$54.83B+16.0%
Danaher logo
DanaherDHR
$47.41B+10.3%
Bruker logo
BrukerBRKR
$1.43B-13.3%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$4.51M0.0%
Revvity logo
RevvityRVTY
$6.61B+1.5%
Agilent Technologies logo
Agilent TechnologiesA
$4.48B+0.2%

Segments

By segment

See full
Diagnostics And Spatial Biology$553.62M+1.1%
Protein Sciences$424.18M+0.7%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemMarch 31, 2026 / (unaudited)June 30, 2025
Total current assets688,050608,300
Property and equipment, net232,990245,719
Right-of-use assets68,31673,399
Goodwill977,800980,935
Intangible assets, net319,074365,599
Other assets264,371283,916
Total assets$2,550,601$2,557,868
LIABILITIES AND SHAREHOLDERS’ EQUITY

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's goodwill?
Bio-Techne (TECH) reported goodwill of $977.8M in Q1 2026.
How has Bio-Techne's goodwill changed year-over-year?
Bio-Techne's goodwill increased by 0.9% year-over-year, from $968.61M to $977.8M.
What is the long-term trend for Bio-Techne's goodwill?
Over 4 years (2021 to 2025), Bio-Techne's goodwill has grown at a 3.9% compound annual growth rate (CAGR), from $843.07M to $980.94M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.

Ask your AI about Bio-Techne's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude